GURUFOCUS.COM » STOCK LIST » Utilities » Utilities - Independent Power Producers » Orion Pharma Ltd (DHA:ORIONPHARM) » Definitions » Cyclically Adjusted Book per Share

Orion Pharma (DHA:ORIONPHARM) Cyclically Adjusted Book per Share : BDT93.50 (As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Orion Pharma Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Orion Pharma's adjusted book value per share for the three months ended in Mar. 2025 was BDT89.179. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is BDT93.50 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Orion Pharma's average Cyclically Adjusted Book Growth Rate was 2.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2025-06-04), Orion Pharma's current stock price is BDT26.60. Orion Pharma's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was BDT93.50. Orion Pharma's Cyclically Adjusted PB Ratio of today is 0.28.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Orion Pharma was 0.95. The lowest was 0.27. And the median was 0.78.


Orion Pharma Cyclically Adjusted Book per Share Historical Data

The historical data trend for Orion Pharma's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Pharma Cyclically Adjusted Book per Share Chart

Orion Pharma Annual Data
Trend Dec14 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 89.03 91.83

Orion Pharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 91.18 91.83 92.18 92.31 93.50

Competitive Comparison of Orion Pharma's Cyclically Adjusted Book per Share

For the Utilities - Independent Power Producers subindustry, Orion Pharma's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orion Pharma's Cyclically Adjusted PB Ratio Distribution in the Utilities - Independent Power Producers Industry

For the Utilities - Independent Power Producers industry and Utilities sector, Orion Pharma's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Orion Pharma's Cyclically Adjusted PB Ratio falls into.


;
;

Orion Pharma Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Orion Pharma's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=89.179/134.9266*134.9266
=89.179

Current CPI (Mar. 2025) = 134.9266.

Orion Pharma Quarterly Data

Book Value per Share CPI Adj_Book
201412 67.495 99.070 91.924
201503 68.862 99.621 93.267
201506 68.309 100.684 91.541
201509 69.475 100.392 93.375
201606 69.991 101.688 92.869
201609 71.088 101.861 94.164
201612 70.717 101.863 93.671
201703 71.142 102.862 93.319
201706 70.951 103.349 92.630
201709 72.054 104.136 93.359
201712 71.460 104.011 92.700
201803 72.074 105.290 92.362
201806 72.881 106.317 92.493
201809 73.650 106.507 93.303
201812 73.324 105.998 93.335
201903 74.292 107.251 93.463
201906 75.190 108.070 93.876
201909 76.326 108.329 95.066
201912 75.728 108.420 94.242
202003 76.685 108.902 95.011
202006 76.768 108.767 95.231
202009 77.811 109.815 95.604
202012 77.908 109.897 95.652
202103 78.782 111.754 95.117
202106 79.755 114.631 93.875
202109 80.548 115.734 93.905
202112 80.937 117.630 92.839
202203 81.965 121.301 91.172
202206 82.532 125.017 89.074
202209 92.649 125.227 99.826
202212 91.747 125.222 98.857
202303 87.373 127.348 92.573
202306 88.993 128.729 93.278
202309 89.653 129.860 93.151
202312 89.686 129.419 93.502
202403 93.011 131.776 95.235
202406 92.049 132.554 93.697
202409 89.882 133.029 91.164
202412 89.821 133.157 91.015
202503 89.179 134.927 89.179

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Orion Pharma  (DHA:ORIONPHARM) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Orion Pharma's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=26.60/93.50
=0.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Orion Pharma was 0.95. The lowest was 0.27. And the median was 0.78.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Orion Pharma Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Orion Pharma's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Orion Pharma Business Description

Traded in Other Exchanges
N/A
Address
153-154 Tejgaon Industrial Area, Orion House, Dhaka, BGD, 1208
Orion Pharma Ltd is a pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical drugs and medicines. It provides its drugs in various dosage forms including tablet, capsule, syrup, suspension, injection, dry powder for syrup and suspension, for therapeutic groups like anticancer, antibiotics, antidiabetics, anxiolytics, diuretics, cardiovascular drugs, and others. In addition, the company is also involved in power generation activities. It generates maximum revenue from power generation activities. The group principally carries out its business operations and markets its products in Bangladesh.

Orion Pharma Headlines

No Headlines